Seaport Therapeutics, Inc. (SPTX)
NASDAQ: SPTX · Real-Time Price · USD
20.01
+0.41 (2.09%)
At close: Nov 2, 2026, 4:00 PM EST
20.01
0.00 (0.00%)
After-hours: Nov 2, 2026, 4:33 PM EST
Seaport Therapeutics Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Seaport Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $37. The average 1-year stock price forecast is 84.91% higher than the current stock price, while the lowest is $28 (+39.93%) and the highest is $50 (+149.88%).
Price Target: $37 (+84.91%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Seaport Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 5 | 6 | 7 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 6 | 7 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Buy Reiterates $32 | Buy | Reiterates | $32 | +59.92% | Nov 2, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Initiates $28 | Buy | Initiates | $28 | +39.93% | Oct 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $50 | Buy | Reiterates | $50 | +149.88% | Oct 8, 2026 |
| Citi | Citi | Buy Maintains $35 | Buy | Maintains | $35 | +74.91% | Oct 8, 2026 |
| Raymond James | Raymond James | Buy Initiates $46 | Buy | Initiates | $46 | +129.89% | Sep 25, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-5.87
EPS Next Year
-2.50
from -5.87
EPS and Forward PE are based on non-GAAP adjusted numbers.